Header Logo

Connection

Shobna Sawry to Child, Preschool

This is a "connection" page, showing publications Shobna Sawry has written about Child, Preschool.
Connection Strength

0,495
  1. Evaluation of the intensified tuberculosis case finding guidelines for children living with HIV. Int J Tuberc Lung Dis. 2018 11 01; 22(11):1322-1328.
    View in: PubMed
    Score: 0,110
  2. A mechanistic model for long-term immunological outcomes in South African HIV-infected children and adults receiving ART. Elife. 2021 01 14; 10.
    View in: PubMed
    Score: 0,032
  3. Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission. PLoS One. 2020; 15(5):e0233693.
    View in: PubMed
    Score: 0,031
  4. What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies. Pediatr Infect Dis J. 2019 04; 38(4):400-405.
    View in: PubMed
    Score: 0,028
  5. High loss to follow-up of children on antiretroviral treatment in a primary care HIV clinic in Johannesburg, South Africa. Medicine (Baltimore). 2018 Jul; 97(29):e10901.
    View in: PubMed
    Score: 0,027
  6. Time to First-Line ART Failure and Time to Second-Line ART Switch in the IeDEA Pediatric Cohort. J Acquir Immune Defic Syndr. 2018 06 01; 78(2):221-230.
    View in: PubMed
    Score: 0,027
  7. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe. Int J Epidemiol. 2017 04 01; 46(2):453-465.
    View in: PubMed
    Score: 0,025
  8. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia. Clin Infect Dis. 2016 11 01; 63(9):1245-1253.
    View in: PubMed
    Score: 0,024
  9. Incidence of AIDS-defining and Other Cancers in HIV-positive Children in South Africa: Record Linkage Study. Pediatr Infect Dis J. 2016 06; 35(6):e164-70.
    View in: PubMed
    Score: 0,023
  10. Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis. Epidemiology. 2016 Mar; 27(2):237-46.
    View in: PubMed
    Score: 0,023
  11. Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression. Pediatr Infect Dis J. 2015 Dec; 34(12):1361-4.
    View in: PubMed
    Score: 0,023
  12. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children. Pediatr Pulmonol. 2016 Feb; 51(2):157-64.
    View in: PubMed
    Score: 0,022
  13. Virologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South Africa. Pediatr Infect Dis J. 2015 Feb; 34(2):175-9.
    View in: PubMed
    Score: 0,021
  14. Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir. J Antimicrob Chemother. 2015 Feb; 70(2):543-9.
    View in: PubMed
    Score: 0,021
  15. The effect of tuberculosis treatment on virologic and immunologic response to combination antiretroviral therapy among South African children. J Acquir Immune Defic Syndr. 2014 Oct 01; 67(2):136-44.
    View in: PubMed
    Score: 0,021
  16. Tuberculosis Immune Reconstitution Inflammatory Syndrome in children initiating Antiretroviral Therapy for HIV infection: A systematic literature review. Pediatr Infect Dis J. 2014 May; 33(5):499-503.
    View in: PubMed
    Score: 0,020
  17. Neurodevelopmental delay among HIV-infected preschool children receiving antiretroviral therapy and healthy preschool children in Soweto, South Africa. Psychol Health Med. 2012; 17(5):599-610.
    View in: PubMed
    Score: 0,017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.